Open access peer-reviewed chapter

Role of Dipeptidyl Peptidase IV/CD26 in Inflammatory Bowel Disease

By Dijana Detel, Lara Batičić Pučar, Ester Pernjak Pugel, Natalia Kučić, Sunčica Buljević, Brankica Mijandrušić Sinčić, Mladen Peršić and Jadranka Varljen

Submitted: March 7th 2011Reviewed: August 24th 2011Published: January 27th 2012

DOI: 10.5772/29285

Downloaded: 2227

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Dijana Detel, Lara Batičić Pučar, Ester Pernjak Pugel, Natalia Kučić, Sunčica Buljević, Brankica Mijandrušić Sinčić, Mladen Peršić and Jadranka Varljen (January 27th 2012). Role of Dipeptidyl Peptidase IV/CD26 in Inflammatory Bowel Disease, Inflammatory Bowel Disease, Sami Karoui, IntechOpen, DOI: 10.5772/29285. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/inflammatory-bowel-disease-advances-in-pathogenesis-and-management/role-of-dipeptidyl-peptidase-iv-cd26-in-inflammatory-bowel-disease" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

2227total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

The Roles of Interleukin-17 and T Helper 17 Cells in Intestinal Barrier Function

By Elizabeth Trusevych, Leanne Mortimer and Kris Chadee

Related Book

First chapter

Alteration of the Crypt Epithelial-Stromal Interface by Proinflammatory Cytokines in Crohn's Disease

By Amira Seltana, Manon Lepage and Jean-François Beaulieu

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More about us